Lamictal TM, Haloperidol Decanoate in Schizophrenia

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
The purpose of this study is to determine the effect of lamotrigine augmentation of Haloperidol decanoate in the treatment of Resistant Schizophrenia predominantly by verbal resistant hallucinosis: A randomized, double-blind, placebo-controlled, study. Nadir A.Aliyev \& Zafar N.Aliyev Central Mental Clinic for Outpatients of Baku city of Azerbaijan Republic Abstract: OBJECTIVE: The current paper reports on a double-blind, randomized study of the role of lamotrigine as an augmentation agent to haloperidol decanoate in the treatment of out patient\'s schizophrenia with verbal resistant hallucinosis.
Epistemonikos ID: 8cb35fb223e346315e34674292eee2496980d699
First added on: May 05, 2024